Rapiscan is the only approved hyperaemic stress agent for myocardial perfusion imaging (MPI) and fractional flow reserve (FFR)1
Rapiscan is a pharmacological stress agent used to simulate the effect of exercise (for those who are unable to exercise). It is used in the diagnosis of coronary artery disease, ensuring subsequent treatment is optimised.1
Rapiscan was developed specifically to address the needs of nuclear medicine and interventional cardiology by simplifying the pharmacological stress protocol, improving patient tolerability and providing an option for patients with asthma and COPD.1
1.GE Healthcare. Rapiscan Summary of Product Characteristics, 2019.